drugset / Trial / NCT01528007

Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

NCT01528007

Phase 4 Completed 100 enrolled Finnish Institute for Health and Welfare
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this research is to explore the efficacy of the opiate antagonist, naltrexone as combined with CBT-intervention in the treatment of pathological gambling (PG). The study period is 2011-2014 during which one hundred Pathological Gamblers will be recruited to participate to this placebo-controlled double-blind trial.

Timeline

Start
2011-01
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule 50 mg

Indications